Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood–brain barrier
- 30 September 1997
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 25 (1) , 27-49
- https://doi.org/10.1016/s0165-0173(97)00014-3
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part II)Clinical Pharmacokinetics, 1992
- Uses and Limitations of Positron Emission Tomography in Clinical Pharmacokinetics/Dynamics (Part I)1Clinical Pharmacokinetics, 1992
- Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophyllineLife Sciences, 1991
- Continuous monitoring of unbound flomoxef levels in rat blood using microdialysis and its new pharmacokinetic analysis.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- The use of an “internal standard” for control of the recovery in microdialysisLife Sciences, 1991
- Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitroLife Sciences, 1990
- The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous systemJournal of Pharmacokinetics and Biopharmaceutics, 1989
- Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systemsLife Sciences, 1987
- A small, removable microdialysis probeLife Sciences, 1986